Bioinformatics-based study on the clinical significance of miR-151a-5p in cervical cancer and its effects on the biological characteristics of cervical cancer cells

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500109495

Enrollment

Unknown

Registered

2025-09-19

Start date

2025-09-19

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Single group (all enrolled patients undergo tissue/cell experiments):No therapeutic intervention

only tissue sample collection and laboratory analysis

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1 Pathologically confirmed cervical cancer; 2 Primary tumor; 3 No prior anti-cancer treatment before surgery; 4 Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1 Presence of other malignancies; 2 Pregnancy or breastfeeding; 3 Severe hepatic or renal dysfunction, or hematologic disorders; 4 Immune dysfunction.

Design outcomes

Primary

Measure	Time frame
Expression levels of miR-151a-5p in cervical cancer and adjacent tissues;Biological characteristics of SiHa cell line (proliferation, migration, invasion, apoptosis, etc.);Correlation analysis with clinicopathological parameters;	—

Countries

China

Contacts

Public ContactJi Ying

Rugao People’s Hospital

419254176@qq.com+86 513 8731 2710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026